The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy

PURPOSE: We evaluated the prognostic quality of the novel pancreas cancer prognostic index (PCPI), a combination of CA 19-9 and systemic inflammation response index (SIRI), on the outcomes of locally advanced pancreas adenocarcinoma (LAPAC) patients who received concurrent chemoradiotherapy (C-CRT)....

Descripción completa

Detalles Bibliográficos
Autores principales: Topkan, Erkan, Selek, Ugur, Pehlivan, Berrin, Kucuk, Ahmet, Haksoyler, Veysel, Kilic Durankus, Nulifer, Sezen, Duygu, Bolukbasi, Yasemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427684/
https://www.ncbi.nlm.nih.gov/pubmed/34511977
http://dx.doi.org/10.2147/JIR.S329611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427684/
https://www.ncbi.nlm.nih.gov/pubmed/34511977
http://dx.doi.org/10.2147/JIR.S329611

Ejemplares similares